University of Southern California: Pancreatic Neoplasms trials

The registry lists 10 Pancreatic Neoplasms studies with University of Southern California as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 1 3Phase 2 3No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Contrast EUS of the PancreasRecruitingNCT02863770Not applicable
• CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except MelanomaTerminatedNCT04387071Phase 1/2Results posted
• Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate CancerWithdrawnNCT03563352
• Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder CancerActive, not recruitingNCT03257761Phase 1
• Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon CancerTerminatedNCT03137706
• EUS Fiducial for Pancreas SurgeryStatus unknownNCT02863783Not applicable
• Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid TumorsActive, not recruitingNCT02495896Phase 1
• Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.TerminatedNCT00159471Not applicable
• Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic CancerTerminatedNCT00003085Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Cancer of the PancreasCompletedNCT00002955Phase 2